| |
 |
|
Class Information
Number: 514/183
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai
Description: Subject matter which includes a compound containing a ring composed of carbon and at least one element from the group consisting of nitrogen, sulfur, selenium, tellurium and oxygen as DOAI.
Sub-classes under this class:
| Class Number |
Class Name |
Patents |
| 514/184 |
Heavy metal containing (including salts) |
555 |
| 514/191 |
Aluminum (including salts) |
54 |
| 514/192 |
1-thia-4-aza-bicyclo (3.2.0) heptane ring containing (including dehydrogenated) (e.g., penicillins, etc.) |
269 |
| 514/200 |
1-thia-5-aza-bicyclo (4.2.0) octane ring containing (including dehydrogenated) (e.g., cephalosporins, etc.) |
180 |
| 514/210.01 |
Hetero ring is four-membered and includes at least one ring nitrogen |
166 |
| 514/211.01 |
Hetero ring contains seven members including nitrogen, carbon and chalcogen |
167 |
| 514/212.01 |
Hetero ring is seven-membered consisting of one nitrogen and six carbons |
229 |
| 514/218 |
Hetero ring is seven-membered consisting of two nitrogens and five carbon atoms |
853 |
| 514/222.2 |
Hetero ring is six-membered and includes at least nitrogen and sulfur as ring members |
166 |
| 514/228.8 |
Hetero ring is six-membered and includes at least nitrogen and oxygen as ring hetero atoms (e.g., monocyclic 1,2- and 1,3-oxazines, etc.) |
265 |
| 514/241 |
Hetero ring is six-membered consisting of three nitrogens and three carbon atoms |
587 |
| 514/247 |
Hetero ring is six-membered consisting of two nitrogens and four carbon atoms (e.g., pyridazines, etc.) |
741 |
| 514/277 |
Hetero ring is six-membered consisting of one nitrogen and five carbon atoms |
864 |
| 514/359 |
Five-membered hetero ring containing at least one nitrogen ring atom (e.g., 1,2,3-triazoles, etc.) |
597 |
| 514/430 |
Sulfur containing hetero ring |
107 |
| 514/449 |
Oxygen containing hetero ring |
562 |
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 6906050 |
Substituted porphyrin and azaporphyrin derivatives and their use in photodynamic therapy, radioimaging and MRI diagnosis |
Jun. 14, 2005 |
| 6906051 |
Lactone integrin antagonists |
Jun. 14, 2005 |
| 6906052 |
Diagnosis and treatment of human kidney diseases |
Jun. 14, 2005 |
| 6906053 |
Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-.alpha. converting enzyme (TACE) |
Jun. 14, 2005 |
| 6906106 |
Compositions for the skin comprising fibers and ubiquinones and methods of using the same |
Jun. 14, 2005 |
| 6903052 |
Nematicidal compositions and methods |
Jun. 7, 2005 |
| 6903085 |
Substituted piperidine compounds useful as modulators of chemokine receptor activity |
Jun. 7, 2005 |
| 6903086 |
Alkoxycarbonylamino benzoic acid or alkoxycarbonylamino tetrazolyl phenyl derivatives as IP antagonists |
Jun. 7, 2005 |
| 6903087 |
Pyrido cyclohexenyl phenyl carboxamides tocolytic oxytocin receptor antagonists |
Jun. 7, 2005 |
| 6903088 |
Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
Jun. 7, 2005 |
| 6900194 |
Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases |
May. 31, 2005 |
| 6900195 |
Manzamines for treatment of drug resistant infection |
May. 31, 2005 |
| 6900196 |
Serine protease inhibitors |
May. 31, 2005 |
| 6897207 |
Azaindoles |
May. 24, 2005 |
| 6897208 |
Benzimidazoles |
May. 24, 2005 |
| 6897209 |
Labelled factor XIIIa substrates |
May. 24, 2005 |
| 6897210 |
Quinazoline derivatives and pharmaceutical compositions containing them |
May. 24, 2005 |
| 6894039 |
Selenophene anti-tumor agents |
May. 17, 2005 |
| 6890915 |
Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-.alpha. converting enzyme (TACE) |
May. 10, 2005 |
| 6890916 |
Indole derivatives useful for the treatment of CNS disorders |
May. 10, 2005 |
| 6890917 |
Geldanamycin derivative and method of treating cancer using same |
May. 10, 2005 |
| 6887853 |
Use of geldanamycin and related compounds for treatment of fibrogenic disorders |
May. 3, 2005 |
| 6887862 |
Method for improving treatment selectivity and efficacy using intravascular photodynamic therapy |
May. 3, 2005 |
| 6887863 |
Hydrazide and alkoxyamide angiogenesis inhibitors |
May. 3, 2005 |
| 6884783 |
7-Hydroxy chromones as potent antioxidants |
Apr. 26, 2005 |
| 6884811 |
Antifungal composition |
Apr. 26, 2005 |
| 6881409 |
Compositions and methods for promoting nerve regeneration |
Apr. 19, 2005 |
| 6881731 |
Enhancers for microbiological disinfection |
Apr. 19, 2005 |
| 6881732 |
Neuroprotection and cardioprotection afforded by chelators with high affinity and specificity for cations of first transition series elements |
Apr. 19, 2005 |
| 6878700 |
Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
Apr. 12, 2005 |
| 6878701 |
Potassium channel blocking agents |
Apr. 12, 2005 |
| 6875451 |
Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds |
Apr. 5, 2005 |
| 6875727 |
Use of macrolides in pest control |
Apr. 5, 2005 |
| 6875759 |
Substituted guanidines and the use thereof |
Apr. 5, 2005 |
| 6875760 |
Glucagon antagonists/inverse agonists |
Apr. 5, 2005 |
| 6875761 |
Certain 1,3-disubstituted isoquinoline derivatives |
Apr. 5, 2005 |
| 6872714 |
Methods to modulate conditions mediated by the CXCR4 receptor |
Mar. 29, 2005 |
| 6872715 |
Benzoquinone ansamycins |
Mar. 29, 2005 |
| 6872716 |
Antipsychotic sulfonamide-heterocycles, and methods of use thereof |
Mar. 29, 2005 |
| 6869943 |
Sorbitol dehydrogenase inhibitors |
Mar. 22, 2005 |
| 6867200 |
(Hetero)aryl-bicyclic heteroaryl derivatives, their preparation and their use as protease inhibitors |
Mar. 15, 2005 |
| 6867201 |
Heteroaromatic bicyclic derivatives useful as anticancer agents |
Mar. 15, 2005 |
| 6867202 |
Treatment of insulin resistance |
Mar. 15, 2005 |
| 6867203 |
Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
Mar. 15, 2005 |
| 6867209 |
Indole-type derivatives as inhibitors of p38 kinase |
Mar. 15, 2005 |
| 6867231 |
Therapeutic systems |
Mar. 15, 2005 |
| 6861416 |
Oxazinones and methods for their use and synthesis |
Mar. 1, 2005 |
| 6861417 |
Pyridin-4-YL or pyrimidin-4-YL substituted pyrazines |
Mar. 1, 2005 |
| 6861418 |
4-aryl substituted indolinones |
Mar. 1, 2005 |
| 6858598 |
Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia |
Feb. 22, 2005 |
|
|
|
